Literature DB >> 20964551

Prevalence of depression among postmenopausal women and related characteristics.

A Unsal1, M Tozun, U Ayranci.   

Abstract

OBJECTIVE: To estimate the prevalence of depression in postmenopausal women and to evaluate the relation between postmenopausal depression and some sociodemographic characteristics.
METHODS: This cross-sectional study was conducted in 744 postmenopausal women aged 45-65 years residing within Sivrihisar, Eskisehir, a town in western Turkey. The study was conducted between May 1 and June 30, 2009. Depression was measured with a Turkish version of the Beck Depression Inventory. Data were gathered during routine visits to the women's homes. Following the completion of the questionnaires and scales, the women's body mass indices were calculated by measuring their heights and weights. Statistical analysis used the χ(2) test and the Wald backward stepwise method. A value of p < 0.05 was considered statistically significant.
RESULTS: The prevalence of depression was 24.7% (184/744). The average age of the women at menopause was 46 years. Significantly important risk factors for depression were primary-school education level (odds ratio (OR) 1.681), not being married (OR 1.653), having a history of psychiatric illness (OR 2.186), entering into menopause at the age of  ≤39 years (OR 2.705), having irregular menstruation before menopause (OR 1.729), and having no children (OR 3.316).
CONCLUSION: Depression among postmenopausal women is an important public health problem that requires attention; furthermore, women are at risk in terms of depression after entering into menopause.

Entities:  

Mesh:

Year:  2010        PMID: 20964551     DOI: 10.3109/13697137.2010.510912

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  13 in total

1.  An Elevated FIB-4 Score Is Associated with an Increased Incidence of Depression among Outpatients in Germany.

Authors:  David Schöler; Karel Kostev; Münevver Demir; Mark Luedde; Marcel Konrad; Tom Luedde; Christoph Roderburg; Sven H Loosen
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

2.  Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study.

Authors:  Jingjing Zhou; Xiao Wang; Lei Feng; Le Xiao; Rui Yang; Xuequan Zhu; Hui Shi; Yongdong Hu; Runsen Chen; Philip Boyce; Gang Wang
Journal:  BMC Psychiatry       Date:  2021-05-19       Impact factor: 3.630

Review 3.  Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods.

Authors:  Claudia Barth; Arno Villringer; Julia Sacher
Journal:  Front Neurosci       Date:  2015-02-20       Impact factor: 4.677

4.  Analysis of Sociodemographic, Psychological, and Genetic Factors Contributing to Depressive symptoms in Pre-, Peri- and Postmenopausal Women.

Authors:  Elżbieta Grochans; Małgorzata Szkup; Artur Kotwas; Jacek Kopeć; Beata Karakiewicz; Anna Jurczak
Journal:  Int J Environ Res Public Health       Date:  2018-04-10       Impact factor: 3.390

5.  Dietary total antioxidant capacity is inversely associated with depression, anxiety and some oxidative stress biomarkers in postmenopausal women: a cross-sectional study.

Authors:  Maryam Abshirini; Fereydoun Siassi; Fariba Koohdani; Mostafa Qorbani; Hadis Mozaffari; Zahra Aslani; Mahshid Soleymani; Mahdieh Entezarian; Gity Sotoudeh
Journal:  Ann Gen Psychiatry       Date:  2019-03-19       Impact factor: 3.455

6.  Prevalence of Depression and its Association with Sociodemographic Factors in Postmenopausal Women in an Urban Resettlement Colony of Delhi.

Authors:  Pooja Ahlawat; M Meghachandra Singh; Suneela Garg; Y M Mala
Journal:  J Midlife Health       Date:  2019 Jan-Mar

7.  Depressive Symptoms and Healthy Behavior Frequency in Polish Postmenopausal Women from Urban and Rural Areas.

Authors:  Mariusz Gujski; Dorota Raczkiewicz; Ewa Humeniuk; Beata Sarecka-Hujar; Artur Wdowiak; Iwona Bojar
Journal:  Int J Environ Res Public Health       Date:  2021-03-14       Impact factor: 3.390

8.  Biopsychosocial risk factors of depression during menopause transition in southeast China.

Authors:  Ketan Chu; Jing Shui; Linjuan Ma; Yizhou Huang; Fan Wu; Fang Wei; Xingjun Meng; Jie Luo; Fei Ruan; Jianhong Zhou
Journal:  BMC Womens Health       Date:  2022-07-05       Impact factor: 2.742

9.  Increased depression and metabolic risk in postmenopausal breast cancer survivors.

Authors:  Monica C Serra; Andrew P Goldberg; Alice S Ryan
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

10.  Perimenopausal syndrome and mood disorders in perimenopause: prevalence, severity, relationships, and risk factors.

Authors:  Rui-Xia Li; Min Ma; Xi-Rong Xiao; Yan Xu; Xiu-Ying Chen; Bin Li
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.